The study was planned as a cross-sectional cohort study. Our study was conducted in the outpatient clinic of Erenkoy Mental and Nervous Diseases Training and Research Hospital, Istanbul, Turkey. Patients who were enrolled into the study were diagnosed with BD-I by using the Structured Clinical Interview for The Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 disorders—Clinician Version (SCID-5-CV) affective disorders section.21 (link) Patients between the ages of 18 and 60 and being in remission (<7 points for the Young Mania Rating Scale and <7 points for the Hamilton Depression Rating Scale for at least 8 weeks before the participation) were included in the study.
Patients with major neurological disease history (epilepsy, multiple sclerosis, dementia, Parkinson’s, etc., motor disorders, history of intracranial operation, severe head trauma and contusion, intracranial hypertension, etc.), illiteracy, having any additional psychiatric diagnosis (anxiety disorders, psychotic disorder, substance use disorder, attention deficit hyperactivity disorder, personality disorder, organic mental disorder, etc.) were excluded from the study. Around 82 consecutively admitted patients were assessed and 10 patients were excluded from the study due to unremitted symptoms as a result of the scales. The patients who were eligible for the study were included in the study after verbal and written informed consent was obtained. This study was conducted in accordance with the Declaration of Helsinki, and approval was obtained from the Ethics Committee of Erenkoy Mental and Nervous Diseases Training and Research Hospital (2021.2.1/8).
Patients with major neurological disease history (epilepsy, multiple sclerosis, dementia, Parkinson’s, etc., motor disorders, history of intracranial operation, severe head trauma and contusion, intracranial hypertension, etc.), illiteracy, having any additional psychiatric diagnosis (anxiety disorders, psychotic disorder, substance use disorder, attention deficit hyperactivity disorder, personality disorder, organic mental disorder, etc.) were excluded from the study. Around 82 consecutively admitted patients were assessed and 10 patients were excluded from the study due to unremitted symptoms as a result of the scales. The patients who were eligible for the study were included in the study after verbal and written informed consent was obtained. This study was conducted in accordance with the Declaration of Helsinki, and approval was obtained from the Ethics Committee of Erenkoy Mental and Nervous Diseases Training and Research Hospital (2021.2.1/8).
